Pediatric glioblastoma in the setting of constitutional mismatch-repair deficiency treated with upfront lomustine and nivolumab

Pediatr Blood Cancer. 2024 Jan;71(1):e30757. doi: 10.1002/pbc.30757. Epub 2023 Oct 26.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Brain Neoplasms* / drug therapy
  • Child
  • Colorectal Neoplasms*
  • Glioblastoma* / drug therapy
  • Humans
  • Lomustine
  • Neoplastic Syndromes, Hereditary
  • Nivolumab

Substances

  • Lomustine
  • Nivolumab

Supplementary concepts

  • Turcot syndrome